Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in STEMI
NCT01938235Phase 2Unknown
- Sponsor
- University Health Network
- Start
- Feb 2014
- Primary completion
- Jul 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Exenatide with Placebo (2 arms). Primary endpoint: Ratio of final infarct size over area at risk at 3 months. Status: unknown.
02
Drugs
exenatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01938235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01938235.